HIV Patients Stick With Other Groups To Defend Protected Drug Classes

By John Wilkerson
February 11, 2019 at 4:29 PM
Advocates for HIV/AIDS patients are using the administration’s initiative to end the HIV epidemic to argue against a CMS proposal that would let Part D plans restrict coverage of HIV drugs, which currently are a protected class in Part D. However, HIV patient groups are maintaining a unified front with groups that represent patients who need drugs in the other protected classes, rather than requesting special treatment for HIV drugs. In his State of the Union address on Feb. 5,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.